Financial Architects (New Jersey)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Financial Architects (New Jersey)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6	Closed	-$3K	–	323
2020 Q2	$3K	Hold	6	–	–	﹤0.01%	769
2020 Q1	$2K	Hold	6	–	–	﹤0.01%	769
2019 Q4	$2K	Hold	6	–	–	﹤0.01%	828
2019 Q3	$2K	Hold	6	–	–	﹤0.01%	899
2019 Q2	$2K	Hold	6	–	–	﹤0.01%	1080
2019 Q1	$2K	Hold	6	–	–	﹤0.01%	1317
2018 Q4	$1K	Hold	6	–	–	﹤0.01%	1258
2018 Q3	$2K	Hold	6	–	–	﹤0.01%	1320
2018 Q2	$2K	Buy	+6	New	+$1.66K	﹤0.01%	1202

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Financial Architects (New Jersey)'s BIO Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 6 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in BIO in Q2 2018 and held it in 9 quarters. The position peaked at $3K in Q2 2020. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

Financial Architects (New Jersey) reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 6 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $3K.
Financial Architects (New Jersey) first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 9 quarters.
Financial Architects (New Jersey)'s Bio-Rad Laboratories Class A position peaked at $3K in Q2 2020.
479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.